CN111904877A - Nanoemulsion preparation based on hyaluronic acid micro molecules and preparation method thereof - Google Patents

Nanoemulsion preparation based on hyaluronic acid micro molecules and preparation method thereof Download PDF

Info

Publication number
CN111904877A
CN111904877A CN202010801878.0A CN202010801878A CN111904877A CN 111904877 A CN111904877 A CN 111904877A CN 202010801878 A CN202010801878 A CN 202010801878A CN 111904877 A CN111904877 A CN 111904877A
Authority
CN
China
Prior art keywords
hyaluronic acid
preparation
surfactant
oil
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010801878.0A
Other languages
Chinese (zh)
Inventor
李尤红
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Jiasheng Health Technology Co ltd
Original Assignee
Guangzhou Jiasheng Health Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Jiasheng Health Technology Co ltd filed Critical Guangzhou Jiasheng Health Technology Co ltd
Priority to CN202010801878.0A priority Critical patent/CN111904877A/en
Publication of CN111904877A publication Critical patent/CN111904877A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/068Microemulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses a nano-emulsion preparation based on hyaluronic acid micro-molecules and a preparation method thereof, wherein the preparation comprises 0.1-3% of hyaluronic acid, 0.1-10% of surfactant, 0.1-20% of cosurfactant, 0.1-10% of solvent, 0.5-20% of oil phase, 0.01-1% of preservative, 0.01-1% of spice and 54-95% of distilled water. The nanometer emulsion preparation has the advantages of reduced particle size of hyaluronic acid molecules, improved transdermal property, simple preparation process, and low cost.

Description

Nanoemulsion preparation based on hyaluronic acid micro molecules and preparation method thereof
Technical Field
The invention relates to the technical field of cosmetics, in particular to a nano-emulsion preparation based on hyaluronic acid micro-molecules and a preparation method thereof.
Background
Hyaluronic acid, also known as hyaluronic acid, is widely used as a wrinkle-removing filling material in the field of cosmetic surgery. In the field of skin care, hyaluronic acid is always a good moisturizing and anti-aging component, but the development of hyaluronic acid in the field of skin care cosmetics is limited due to overlarge molecular weight, poor transdermal property and the like.
Disclosure of Invention
In view of the above disadvantages, it is an object of the present invention to provide a nano-emulsion preparation based on hyaluronic acid micro-molecules and a method for preparing the same.
In order to solve the technical problems, the invention adopts the following technical scheme:
the invention provides a hyaluronic acid nanoemulsion preparation, which consists of 0.1-3% of hyaluronic acid, 0.1-10% of surfactant, 0.1-20% of cosurfactant, 0.1-10% of solvent, 0.5-20% of oil phase, 0.01-1% of preservative, 0.01-1% of spice and 54-95% of distilled water.
Preferably, the molecular weight of the hyaluronic acid is 800-.
Preferably, the surfactant is any one or combination of more of Tween-80, Tween-60, triglyceride, sodium lauryl sulfate, polyoxyethylene lauryl ether and polyoxyethylene hydrogenated castor oil.
Preferably, the cosurfactant is any one or combination of sorbitan monostearate, propylene glycol monostearate, glyceryl monostearate, span 20, span 60 and span 80.
Preferably, the oil is any one or combination of edible tricaprylin, caprylic/capric triglyceride, soybean oil, medicinal liquid paraffin, edible salad oil, castor oil, isopropyl myristate and ethyl oleate.
Preferably, the solvent is any one or combination of anhydrous ethanol, pentanediol, n-butanol, glycerol and 1, 3-butanediol.
Preferably, the preservative is any one or combination of phenoxyethanol, ethylhexyl glycerol, benzoic acid, sodium benzoate, sorbic acid, potassium sorbate and calcium propionate.
Preferably, the perfume is one or more combination of daily chemical perfumes.
More preferably, the emulsion preparation is any one of essence, toner and spray.
The preparation method of the hyaluronic acid nanoemulsion preparation comprises the following steps:
(1) firstly, dissolving hyaluronic acid by redistilled acetone;
(2) mixing the oil phase, the surfactant, the cosurfactant and the solvent, adding absolute ethyl alcohol which is equal to the total amount of the oil phase, the surfactant, the cosurfactant and the solvent, mixing according to a ratio of 1:1, magnetically stirring for 4 hours, and cooling to below 45 ℃;
(3) slowly adding the hyaluronic acid acetone solution obtained in the step (1) into the solution obtained in the step (2), uniformly stirring by using a high-pressure homogenizer with 1.38 × 108Pa-4.13 × 108Pa, then decompressing to 1.0 × 10-2Pa-1.0 × 104Pa, distilling, removing acetone and ethanol, and cooling to room temperature for later use;
(4) adding water, antiseptic and perfume to obtain hyaluronic acid nanoemulsion.
The invention has the beneficial effects that: the nanometer emulsion preparation has the advantages of reduced particle size of hyaluronic acid molecules, improved transdermal property, simple preparation process, and low cost.
Detailed Description
The technical solutions of the present invention will be described clearly and completely in the following embodiments of the present invention, and it should be understood that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
A hyaluronic acid nanoemulsion preparation comprises 0.1% of hyaluronic acid, 0.4% of Tween-80, 0.5% of sorbitan monostearate, 1.99% of absolute ethyl alcohol, 1.99% of edible tricaprylin, 0.01% of phenoxyethanol, 0.01% of spice and 95% of distilled water.
The preparation method comprises the following steps:
(1) firstly, dissolving hyaluronic acid by redistilled acetone;
(2) mixing the oil phase, the surfactant, the cosurfactant and the solvent, adding absolute ethyl alcohol which is equal to the total amount of the oil phase, the surfactant, the cosurfactant and the solvent, mixing according to a ratio of 1:1, magnetically stirring for 4 hours, and cooling to below 45 ℃;
(3) slowly adding the hyaluronic acid acetone solution obtained in the step (1) into the solution obtained in the step (2), uniformly stirring by using a high-pressure homogenizer with 1.38 × 108Pa-4.13 × 108Pa, then decompressing to 1.0 × 10-2Pa-1.0 × 104Pa, distilling, removing acetone and ethanol, and cooling to room temperature for later use;
(4) adding water, antiseptic and perfume to obtain hyaluronic acid nanoemulsion.
Example 2
A hyaluronic acid nanoemulsion preparation comprises 1% hyaluronic acid, 3% triglyceride, 8% glyceryl monostearate, 3% n-butanol, 7% soybean oil, 0.03% benzoic acid, 0.03% perfume, and 77.94% distilled water.
The preparation method is the same as that of example 1.
Example 3
A hyaluronic acid nanoemulsion preparation is composed of 2% of hyaluronic acid, 7% of polyoxyethylene lauryl ether, 12% of span 60, 8% of glycerol, 13% of medicinal liquid paraffin, 0.05% of potassium sorbate, 0.05% of spice and 57.9% of distilled water.
Example 4
A hyaluronic acid nanoemulsion preparation is composed of 3% of hyaluronic acid, 10% of polyoxyethylene hydrogenated castor oil, 15% of span 80, 4% of 1, 3-butanediol, 12% of ethyl oleate, 1% of calcium propionate, 1% of perfume and 54% of distilled water.
The preparation method is the same as that of example 1.
Comparative example 1
Selecting best example 1 of CN201210434701.7(CN102871936A), referring to the composition and preparation method thereof, the rhodiola root extract is replaced by salidroside of the invention, which comprises the following specific steps:
specific components Weight ratio (%)
Salidroside 0.1
Polyglycerol monooleate 0.5
Tween 80 0.5
Polyoxyethylene Castor oil 0.5
Polyethylene glycol caprylic/capric glycerides 0.5
Soybean lecithin 3.5
Caprylic/capric glycerides 5
Glycerol 69.4
Water (W) 20
The preparation method comprises the following steps: respectively dissolving phospholipid in 70ml chloroform-n-hexane solution (chloroform: n-hexane, 5: 7, v/v), dissolving salidroside in 10ml distilled water, stirring, mixing the two solutions, performing ultrasonic treatment, and freeze drying the obtained emulsion to obtain salidroside-phospholipid complex; mixing salidroside-phospholipid complex, caprylic/capric glyceride, polyglycerol monooleate, tween 80, polyoxyethylene castor oil, and polyethylene glycol caprylic/capric glyceride, and shearing at 8000rpm until no visible solid matter exists in the system; adding glycerol and water into the product obtained in the step 2), and shearing at high speed under 12000rpm to obtain primary emulsion, treating the primary emulsion by a high-pressure homogenizer at 800bar, and circulating for 5 times to obtain transparent clear nanoscale emulsion.
In vitro transdermal test:
first, test sample
Samples 1 to 4: the products prepared in examples 1-4; control 1: the product of comparative example 1. Before testing, the different sample concentrations were normalized to 0.1% by dilution.
Second, test method
A (25 + -5) g male mouse was removed of abdominal hair with 6% Na2S solution, and immediately after neck amputation, abdominal skin was excised, and subcutaneous tissue and fat were removed and washed repeatedly with purified water. The skin was fixed on a diffusion cell with stratum corneum facing up, purified water was used as a receiving solution, the rotational speed was 180rpm, the diffusion area was 3.3cm, the total volume of the receiving cell was 18ml, and water bath circulation was carried out at 37 ℃. Taking 1 g of sample, placing the sample on rat skin, taking 2ml of receiving solution in 1h, 2h, 4h, 6h and 8h respectively, supplementing blank receiving solution with the same volume, measuring the content of each sample by an HPLC method, and calculating the cumulative permeation quantity Q per unit area, wherein the calculation formula is as follows:
q ═ Σ CnV/a (where CN represents the sample concentration of the sample sampled n times, V represents the liquid in the receiving cell, and a represents the diffusion area).
After the third month, the last test was repeated with the product of the invention. The preservation method for 3 months comprises the following steps: placing at 37 deg.C, sealing and standing.
Third, test results
The cumulative permeation per unit area for the different samples is shown in table 1.
TABLE 1 cumulative permeation per unit area for different samples
Name (R) Sample 1 Sample 2 Sample 3 Sample No. 4 Reference 1
Content (wt.) 240.1 258.3 258.9 243.2 113.5
As can be seen from Table 1, the skin penetration of the experimental groups 1-4 was significantly better than that of the control 1.
The cumulative permeation per unit area for the different samples after three months is shown in table 2.
TABLE 2 cumulative permeation per unit area for different samples three months later
Figure BDA0002627695550000051
Figure BDA0002627695550000061
The results in table 2 show that the emulsions provided by the present invention still maintain good absorption after three months.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any changes or substitutions that can be easily conceived by those skilled in the art within the technical scope of the present invention are included in the scope of the present invention. Accordingly, the scope of the invention is to be determined by the claims that follow.

Claims (10)

1. A hyaluronic acid nanoemulsion preparation is characterized by comprising 0.1% -3% of hyaluronic acid, 0.1% -10% of surfactant, 0.1% -20% of cosurfactant, 0.1% -10% of solvent, 0.5% -20% of oil phase, 0.01% -1% of preservative, 0.01% -1% of spice and 54% -95% of distilled water.
2. The milk formulation of claim 1, wherein the hyaluronic acid has a molecular weight of 800-.
3. The emulsion formulation of claim 1, wherein the surfactant is any one or a combination of tween-80, tween-60, triglycerides, sodium lauryl sulfate, polyoxyethylene lauryl ether, polyoxyethylene hydrogenated castor oil.
4. The milk formulation of claim 1, wherein the co-surfactant is any one or a combination of sorbitan monostearate, propylene glycol monostearate, glyceryl monostearate, span 20, span 60 and span 80.
5. The emulsion formulation of claim 1, wherein the oil is one or more of edible tricaprylin, caprylic/capric triglyceride, soybean oil, medicinal liquid paraffin, edible salad oil, castor oil, isopropyl myristate, and ethyl oleate.
6. The emulsion formulation of claim 1, wherein the solvent is any one or a combination of anhydrous ethanol, pentane diol, n-butanol, glycerol, 1, 3-butanediol.
7. The milk preparation of claim 1, wherein the preservative is any one or a combination of phenoxyethanol, ethylhexyl glycerol, benzoic acid, sodium benzoate, sorbic acid, potassium sorbate, and calcium propionate.
8. The milk preparation of claim 1, wherein the flavor is one or more combinations of flavors commonly used in daily use.
9. The emulsion according to any one of claims 1 to 8, wherein the emulsion is a liquid preparation selected from the group consisting of essence, toner, and spray.
10. A process for the preparation of a milk preparation as claimed in claim 9, comprising the steps of:
(1) firstly, dissolving hyaluronic acid by redistilled acetone;
(2) mixing the oil phase, the surfactant, the cosurfactant and the solvent, adding absolute ethyl alcohol which is equal to the total amount of the oil phase, the surfactant, the cosurfactant and the solvent, mixing according to a ratio of 1:1, magnetically stirring for 4 hours, and cooling to below 45 ℃;
(3) slowly adding the hyaluronic acid acetone solution obtained in the step (1) into the solution obtained in the step (2), uniformly stirring by using a high-pressure homogenizer with 1.38 × 108Pa-4.13 × 108Pa, then decompressing to 1.0 × 10-2Pa-1.0 × 104Pa, distilling, removing acetone and ethanol, and cooling to room temperature for later use;
(4) adding water, antiseptic and perfume to obtain hyaluronic acid nanoemulsion.
CN202010801878.0A 2020-08-11 2020-08-11 Nanoemulsion preparation based on hyaluronic acid micro molecules and preparation method thereof Pending CN111904877A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010801878.0A CN111904877A (en) 2020-08-11 2020-08-11 Nanoemulsion preparation based on hyaluronic acid micro molecules and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010801878.0A CN111904877A (en) 2020-08-11 2020-08-11 Nanoemulsion preparation based on hyaluronic acid micro molecules and preparation method thereof

Publications (1)

Publication Number Publication Date
CN111904877A true CN111904877A (en) 2020-11-10

Family

ID=73284096

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010801878.0A Pending CN111904877A (en) 2020-08-11 2020-08-11 Nanoemulsion preparation based on hyaluronic acid micro molecules and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111904877A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004020473A1 (en) * 2002-08-27 2004-03-11 Lg Life Sciences Ltd. Microbeads of natural polysaccharide and hyaluronic acid and processes for preparing the same
CN103919697A (en) * 2013-01-14 2014-07-16 汕头市雅娜化妆品实业有限公司 Skin aging resistance traditional Chinese medicine cosmetic and preparation method thereof
US20150174067A1 (en) * 2013-12-20 2015-06-25 Food Industry Research And Development Institute Microemulsion preconcentrates and microemulsions, and preparation processes of the same
CN107997987A (en) * 2017-12-25 2018-05-08 东莞霖诺盈生物科技有限公司 Hyaluronic acid nanometer emulsion formulation and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004020473A1 (en) * 2002-08-27 2004-03-11 Lg Life Sciences Ltd. Microbeads of natural polysaccharide and hyaluronic acid and processes for preparing the same
CN103919697A (en) * 2013-01-14 2014-07-16 汕头市雅娜化妆品实业有限公司 Skin aging resistance traditional Chinese medicine cosmetic and preparation method thereof
US20150174067A1 (en) * 2013-12-20 2015-06-25 Food Industry Research And Development Institute Microemulsion preconcentrates and microemulsions, and preparation processes of the same
CN107997987A (en) * 2017-12-25 2018-05-08 东莞霖诺盈生物科技有限公司 Hyaluronic acid nanometer emulsion formulation and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
李全林: "《新医药开发与研究 下》", 31 December 2008, 中国医药科技出版社 *

Similar Documents

Publication Publication Date Title
EP0196904B1 (en) Perfluoropolyether compositions
TWI324522B (en) External dermal preparation
KR102428341B1 (en) Composition for the natural surfactant and cosmetic composition containing Saponaria officinalis, Yucca Schidigera and Quillaia saponaria MOLINA
JP2021042241A (en) Composition for external use
KR102248067B1 (en) Cosmetic composition
WO2015147137A1 (en) Ceramide-formulated external agent composition
JP2001233754A (en) Emulsion type skin care preparation
CN112739342A (en) Composition for external use containing ascorbic acid and/or salt thereof
KR20180081205A (en) Ceramide liquid crystal composition and Preparation Method Thereof
CN111904877A (en) Nanoemulsion preparation based on hyaluronic acid micro molecules and preparation method thereof
CN115429713A (en) Moisturizing, repairing and anti-aging composition containing ceramide and preparation method thereof
JP2001163766A (en) Composition containing pentacyclic triterpenic acid, particularly cosmetic composition
KR102247589B1 (en) Cosmetic composition for improving skin comprising the moluccella laevis extraction and the hololeion maximowiczii Kitam. extraction as an effective ingredient
JP2020015665A (en) External preparation for skin
JP5535539B2 (en) Moisturizer
CN114028262A (en) Preparation method and application of azelaic acid ionic salt/eutectic cyclodextrin inclusion compound liposome
JP5795146B2 (en) Moisturizer and external preparation for skin
JP2011046646A (en) Antioxidant and skin external preparation
JP3313148B2 (en) External preparation for skin
KR102265020B1 (en) Cosmetic composition using schisandra chinensis extract containing high concentration of lignan
JP2020015699A (en) Skin cosmetics
JPH0632710A (en) Skin external preparation
JP7398211B2 (en) External composition
KR102333145B1 (en) Cosmetic composition for improving skin moisturization containing spicule and method for preparing the same
KR102381622B1 (en) Stabilizing method of rice bran wax and cosmetic composition containing the stabilized rice bran wax

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20201110

RJ01 Rejection of invention patent application after publication